Gene expression of vitamin d metabolic enzymes at baseline and in response to vitamin d treatment in thyroid cancer cell lines

Robert G Bennett, Shannon E. Wakeley, Frederick G Hamel, Robin R. High, Christopher Korch, Whitney S Goldner

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The association between vitamin D and thyroid cancer is unclear. It is unknown if CYP27A1 or CYP2R1 are present in normal thyroid or cancer cells and there is limited information regarding response to treatment with vitamin D. SV40 immortalized follicular cells (N-thy) and six thyroid cancer cell lines were treated with 10 μm vitamin D3, 0.1 μm 1,25(OH) 2D3 or vehicle × 24 h. CYP27A1, CYP2R1, CYP27B1 and CYP24A1 mRNA were measured using quantitative real-time-PCR before and after treatment. Cell proliferation was also evaluated in TPC1 and C643 cells after treatment with D3, 25(OH)D3 and 1,25(OH)2D 3. Baseline CYP27A1 and CYP27B1 mRNA were present in all cells, CYP2R1 was higher and CYP24A1 mRNA was lower in cancer cell lines versus N-thy. TPC1 cells had increased CYP24A1 mRNA levels when treated with both D 3 (3.49, p < 0.001) and 1,25(OH)2D3 (5.05, p < 0.001). C643 cells showed increased CYP24A1 mRNA expression when treated with 1,25(OH)2D3 (5.36, p < 0.001). D3, 25(OH)D3 and 1,25(OH)2D3 all significantly decreased cell proliferation in TPC1 and C643 cells. Overall, both cancerous and N-thy cell lines express CYP27A1 and CYP2R1 in addition to CYP27B1, establishing the potential to metabolize D3 to 1,25(OH) 2D3. Additionally, vitamin D3, 25(OH)D 3 and 1,25(OH)2D3 all had an antiproliferative effect on two thyroid cancer cell lines.

Original languageEnglish (US)
Pages (from-to)264-272
Number of pages9
JournalOncology (Switzerland)
Volume83
Issue number5
DOIs
StatePublished - Sep 1 2012

Fingerprint

Thyroid Neoplasms
Vitamins
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
Gene Expression
Cell Line
Enzymes
Messenger RNA
Cholecalciferol
Vitamin D
Cell Proliferation
Real-Time Polymerase Chain Reaction
Vitamin D3 24-Hydroxylase
Neoplasms

Keywords

  • CYP24A1
  • CYP27A1
  • CYP27B1
  • CYP2R1
  • Thyroid cancer
  • Vitamin D

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Gene expression of vitamin d metabolic enzymes at baseline and in response to vitamin d treatment in thyroid cancer cell lines. / Bennett, Robert G; Wakeley, Shannon E.; Hamel, Frederick G; High, Robin R.; Korch, Christopher; Goldner, Whitney S.

In: Oncology (Switzerland), Vol. 83, No. 5, 01.09.2012, p. 264-272.

Research output: Contribution to journalArticle

@article{5f607e1ed11140b78546c4cf49c80c17,
title = "Gene expression of vitamin d metabolic enzymes at baseline and in response to vitamin d treatment in thyroid cancer cell lines",
abstract = "The association between vitamin D and thyroid cancer is unclear. It is unknown if CYP27A1 or CYP2R1 are present in normal thyroid or cancer cells and there is limited information regarding response to treatment with vitamin D. SV40 immortalized follicular cells (N-thy) and six thyroid cancer cell lines were treated with 10 μm vitamin D3, 0.1 μm 1,25(OH) 2D3 or vehicle × 24 h. CYP27A1, CYP2R1, CYP27B1 and CYP24A1 mRNA were measured using quantitative real-time-PCR before and after treatment. Cell proliferation was also evaluated in TPC1 and C643 cells after treatment with D3, 25(OH)D3 and 1,25(OH)2D 3. Baseline CYP27A1 and CYP27B1 mRNA were present in all cells, CYP2R1 was higher and CYP24A1 mRNA was lower in cancer cell lines versus N-thy. TPC1 cells had increased CYP24A1 mRNA levels when treated with both D 3 (3.49, p < 0.001) and 1,25(OH)2D3 (5.05, p < 0.001). C643 cells showed increased CYP24A1 mRNA expression when treated with 1,25(OH)2D3 (5.36, p < 0.001). D3, 25(OH)D3 and 1,25(OH)2D3 all significantly decreased cell proliferation in TPC1 and C643 cells. Overall, both cancerous and N-thy cell lines express CYP27A1 and CYP2R1 in addition to CYP27B1, establishing the potential to metabolize D3 to 1,25(OH) 2D3. Additionally, vitamin D3, 25(OH)D 3 and 1,25(OH)2D3 all had an antiproliferative effect on two thyroid cancer cell lines.",
keywords = "CYP24A1, CYP27A1, CYP27B1, CYP2R1, Thyroid cancer, Vitamin D",
author = "Bennett, {Robert G} and Wakeley, {Shannon E.} and Hamel, {Frederick G} and High, {Robin R.} and Christopher Korch and Goldner, {Whitney S}",
year = "2012",
month = "9",
day = "1",
doi = "10.1159/000342093",
language = "English (US)",
volume = "83",
pages = "264--272",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "5",

}

TY - JOUR

T1 - Gene expression of vitamin d metabolic enzymes at baseline and in response to vitamin d treatment in thyroid cancer cell lines

AU - Bennett, Robert G

AU - Wakeley, Shannon E.

AU - Hamel, Frederick G

AU - High, Robin R.

AU - Korch, Christopher

AU - Goldner, Whitney S

PY - 2012/9/1

Y1 - 2012/9/1

N2 - The association between vitamin D and thyroid cancer is unclear. It is unknown if CYP27A1 or CYP2R1 are present in normal thyroid or cancer cells and there is limited information regarding response to treatment with vitamin D. SV40 immortalized follicular cells (N-thy) and six thyroid cancer cell lines were treated with 10 μm vitamin D3, 0.1 μm 1,25(OH) 2D3 or vehicle × 24 h. CYP27A1, CYP2R1, CYP27B1 and CYP24A1 mRNA were measured using quantitative real-time-PCR before and after treatment. Cell proliferation was also evaluated in TPC1 and C643 cells after treatment with D3, 25(OH)D3 and 1,25(OH)2D 3. Baseline CYP27A1 and CYP27B1 mRNA were present in all cells, CYP2R1 was higher and CYP24A1 mRNA was lower in cancer cell lines versus N-thy. TPC1 cells had increased CYP24A1 mRNA levels when treated with both D 3 (3.49, p < 0.001) and 1,25(OH)2D3 (5.05, p < 0.001). C643 cells showed increased CYP24A1 mRNA expression when treated with 1,25(OH)2D3 (5.36, p < 0.001). D3, 25(OH)D3 and 1,25(OH)2D3 all significantly decreased cell proliferation in TPC1 and C643 cells. Overall, both cancerous and N-thy cell lines express CYP27A1 and CYP2R1 in addition to CYP27B1, establishing the potential to metabolize D3 to 1,25(OH) 2D3. Additionally, vitamin D3, 25(OH)D 3 and 1,25(OH)2D3 all had an antiproliferative effect on two thyroid cancer cell lines.

AB - The association between vitamin D and thyroid cancer is unclear. It is unknown if CYP27A1 or CYP2R1 are present in normal thyroid or cancer cells and there is limited information regarding response to treatment with vitamin D. SV40 immortalized follicular cells (N-thy) and six thyroid cancer cell lines were treated with 10 μm vitamin D3, 0.1 μm 1,25(OH) 2D3 or vehicle × 24 h. CYP27A1, CYP2R1, CYP27B1 and CYP24A1 mRNA were measured using quantitative real-time-PCR before and after treatment. Cell proliferation was also evaluated in TPC1 and C643 cells after treatment with D3, 25(OH)D3 and 1,25(OH)2D 3. Baseline CYP27A1 and CYP27B1 mRNA were present in all cells, CYP2R1 was higher and CYP24A1 mRNA was lower in cancer cell lines versus N-thy. TPC1 cells had increased CYP24A1 mRNA levels when treated with both D 3 (3.49, p < 0.001) and 1,25(OH)2D3 (5.05, p < 0.001). C643 cells showed increased CYP24A1 mRNA expression when treated with 1,25(OH)2D3 (5.36, p < 0.001). D3, 25(OH)D3 and 1,25(OH)2D3 all significantly decreased cell proliferation in TPC1 and C643 cells. Overall, both cancerous and N-thy cell lines express CYP27A1 and CYP2R1 in addition to CYP27B1, establishing the potential to metabolize D3 to 1,25(OH) 2D3. Additionally, vitamin D3, 25(OH)D 3 and 1,25(OH)2D3 all had an antiproliferative effect on two thyroid cancer cell lines.

KW - CYP24A1

KW - CYP27A1

KW - CYP27B1

KW - CYP2R1

KW - Thyroid cancer

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84865846120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865846120&partnerID=8YFLogxK

U2 - 10.1159/000342093

DO - 10.1159/000342093

M3 - Article

C2 - 22992568

AN - SCOPUS:84865846120

VL - 83

SP - 264

EP - 272

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 5

ER -